Overview
Comparing Human Albumin Versus Hydroxyethylstarch in Renal Transplant Recipients
Status:
Completed
Completed
Trial end date:
2019-02-01
2019-02-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
In this study we try to review the possible effects when using modern hydroxyethylstarch solutions 6 % versus albumin 5% during living donor renal transplantation.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Cairo UniversityTreatments:
Hydroxyethyl Starch Derivatives
Criteria
Inclusion Criteria:- end stage renal disease, for living donor renal transplantation
Exclusion Criteria:
- severe cardiac or hepatic dysfunction, re-transplantation, coagulopathy